2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jacobsen, P. Articles by Parving, H.-H. Search for Related Content PubMed PubMed Citation Articles by Jacobsen, P. Articles by Parving, H.-H.

Genetic Variation in the Renin-Angiotensin System and Progression of Diabetic Nephropathy

Peter Jacobsen^*, Lise Tarnow^*, Bendix Carstensen^*, Peter Hovind^*, Odette Poirier and Hans-Henrik Parving^*,

*Steno Diabetes Center, Gentofte, Denmark; Institut National de la Santé et de la Recherche Médicale SC7, Paris, France; and Faculty of Health Science, University of Aarhus, Aarhus, Denmark

Correspondence to Peter Jacobsen, Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark. Phone: +45-44-43-90-97; Fax: +45-44-43-81-60;

ABSTRACT. The impact of polymorphisms in the genes coding for angiotensinogen (M235T), ACE (ID), and angiotensin II type 1 receptor (A¹¹⁶⁶C) on decline in GFR and doubling of s-creatinine or development of ESRD in patients with type 1 diabetes and diabetic nephropathy (DN) was tested. From 1985, all patients (n = 169) who had established diabetic nephropathy and were treated with angiotensin-converting enzyme inhibition (ACE-I) were identified consecutively at Steno Diabetes Center. Patients were followed for a median of 6 yr (range, 3 to 15 yr), with nine (range, three to 29) measurements of GFR (⁵¹Cr-EDTA). In a Cox proportional hazards model corrected for other risk factors, the D allele (ACE/ID) was associated with time to doubling of s-creatinine/ESRD (rate ratio, 1.81 per allele; 95% confidence interval, 1.09 to 3.03; P = 0.02). A new interaction hypothesis was generated demonstrating that the following variables were associated with accelerated decline in GFR: albuminuria (estimate, 2.12 ml/min per yr per 10-fold increase in albuminuria; P < 0.001), mean BP (estimate, 0.88 ml/min per yr per 10 mmHg; P = 0.02), hemoglobin A_1c (estimate, 0.54 min/min per yr per 1%; P = 0.02), and number of M (M235T)/D (ID)/A (A¹¹⁶⁶C) alleles (estimate, 0.45 ml/min per yr per allele; P = 0.049). Number of M/D/A alleles also influenced time to doubling of s-creatinine or ESRD. In this study of patients with type 1 diabetes, the D allele of the ACE/ID polymorphism in addition to nongenetic risk factors independently accelerated progression of DN during ACE-I. Interaction between polymorphisms in the renin-angiotensin system also influenced the loss of kidney function. This new genetic interaction model needs to be confirmed in future studies. E-mail: pkjacobsen@dadlnet.dk

This article has been cited by other articles:

				S. Maeda Review: Genetics of diabetic nephropathy Therapeutic Advances in Cardiovascular Disease, October 1, 2008; 2(5): 363 - 371. [Abstract] [PDF]

				P. Ruggenenti, P. Bettinaglio, F. Pinares, and G. Remuzzi Angiotensin Converting Enzyme Insertion/Deletion Polymorphism and Renoprotection in Diabetic and Nondiabetic Nephropathies Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1511 - 1525. [Abstract] [Full Text] [PDF]

				H.-H. Parving, D. de Zeeuw, M. E. Cooper, G. Remuzzi, N. Liu, J. Lunceford, S. Shahinfar, P. H. Wong, P. A. Lyle, P. Rossing, et al. ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy J. Am. Soc. Nephrol., April 1, 2008; 19(4): 771 - 779. [Abstract] [Full Text] [PDF]

				A. Kretowski, K. McFann, J. E. Hokanson, D. Maahs, G. Kinney, J. K. Snell-Bergeon, R. P. Wadwa, R. H. Eckel, L. Ogden, S. Garg, et al. Polymorphisms of the Renin-Angiotensin System Genes Predict Progression of Subclinical Coronary Atherosclerosis Diabetes, March 1, 2007; 56(3): 863 - 871. [Abstract] [Full Text] [PDF]

				B. R. Conway, D. A. Savage, and A. Peter Maxwell Identifying genes for diabetic nephropathy--current difficulties and future directions Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3012 - 3017. [Full Text] [PDF]

				S. Schon, C. Prante, C. Bahr, L. Tarnow, J. Kuhn, K. Kleesiek, and C. Gotting The Xylosyltransferase I Gene Polymorphism c.343G>T (p.A125S) Is a Risk Factor for Diabetic Nephropathy in Type 1 Diabetes Diabetes Care, October 1, 2006; 29(10): 2295 - 2299. [Abstract] [Full Text] [PDF]

				A. S. Astrup, L. Tarnow, P. Rossing, B. V. Hansen, J. Hilsted, and H.-H. Parving Cardiac Autonomic Neuropathy Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients With Diabetic Nephropathy Diabetes Care, February 1, 2006; 29(2): 334 - 339. [Abstract] [Full Text] [PDF]

				M. P. Winn, N. Daskalakis, R. F. Spurney, and J. P. Middleton Unexpected Role of TRPC6 Channel in Familial Nephrotic Syndrome: Does It Have Clinical Implications? J. Am. Soc. Nephrol., February 1, 2006; 17(2): 378 - 387. [Full Text] [PDF]

				P. De, G. Das, K. Harley, and H. Nair Review: Dual blockade of renin-angiotensin system in diabetic nephropathy: review of literature and local experience The British Journal of Diabetes & Vascular Disease, January 1, 2006; 6(1): 23 - 28. [Abstract] [PDF]

				K. G. Ewens, R. A. George, K. Sharma, F. N. Ziyadeh, and R. S. Spielman Assessment of 115 Candidate Genes for Diabetic Nephropathy by Transmission/Disequilibrium Test Diabetes, November 1, 2005; 54(11): 3305 - 3318. [Abstract] [Full Text] [PDF]

				P. K. Jacobsen Review: Preventing End-Stage Renal Disease in Diabetic Patients -- Dual Blockade of the Renin-Angiotensin System (Part II) Journal of Renin-Angiotensin-Aldosterone System, June 1, 2005; 6(2): 55 - 68. [Abstract] [PDF]

				P. K. Jacobsen Preventing end stage renal disease in diabetic patients -- genetic aspect (part I) Journal of Renin-Angiotensin-Aldosterone System, March 1, 2005; 6(1): 1 - 14. [Abstract] [PDF]

				M. Hueso, P. Alia, F. Moreso, V. Beltran-Sastre, L. Riera, C. Gonzalez, M. Angel Navarro, J. M. Grinyo, E. Navarro, and D. Seron Angiotensin Converting Enzyme Genotype and Chronic Allograft Nephropathy in Protocol Biopsies J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2229 - 2236. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673